World Stem Cell Report to be Published in Regenerative Medicine
News Apr 14, 2011
It was also announced that Regenerative Medicine becomes the platinum media sponsor of the GPI’s 2011 World Stem Cell Summit that will take place in Pasadena, California, October 3-5.
Bernard Siegel, Executive Director of GPI said, “We are proud to partner with the truly superb editorial team at Regenerative Medicine to elevate the World Stem Cell Report to PubMed status. This collaboration will allow the Report to reach an even broader global audience. We will continue to provide an array of specialized articles offering unique insights of leading policy-makers, regulators and experts in law, ethics, advocacy, industry and philanthropy from countries, regions and states. The Report provides a critical unmet need by providing a global framework to understand how the intersection of ethics, law, economics and society impact the advancement of regenerative medicine and the quest for cures.”
Elisa Manzotti, Editorial Director at Future Medicine said “We are delighted to be working with Bernie Siegel and GPI on this exciting collaboration. Our editorial team will take great care to ensure that the World Stem Cell Report articles deliver concise, timely and actionable intelligence to our readers. In becoming a platinum media sponsor of the World Stem Cell Summit, we recognize the Summit’s important role in bringing together leaders from around the globe to chart the future of regenerative medicine.”
The Report will be made available to all attendees at the World Stem Cell Summit. The Summit is the world’s largest interdisciplinary stem cell meeting and is organized this year by GPI, City of Hope, Cedars-Sinai Regenerative Medicine Institute, California Institute of Technology and the California Institute for Regenerative Medicine (CIRM).
The Summit program will feature 170 prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers and experts in law and ethics, who will discuss the latest scientific discoveries, business models, legal and regulatory solutions and best practices.
The Summit is expected to attract more than 2,000 attendees from 25 nations, 60 exhibitors and more than 150 endorsing organizations and media partners.
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE
Heart-muscle Patches Created from Human Cells Improve Recovery from Heart AttacksNews
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.READ MORE